Charles Schwab Investment Management Inc Codexis, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 213,567 shares of CDXS stock, worth $689,821. This represents 0.0% of its overall portfolio holdings.
Number of Shares
213,567
Previous 204,554
4.41%
Holding current value
$689,821
Previous $713,000
7.15%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding CDXS
# of Institutions
126Shares Held
48.2MCall Options Held
33.7KPut Options Held
20.2K-
Black Rock Inc. New York, NY6.79MShares$21.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$13.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.63MShares$11.7 Million0.75% of portfolio
-
Opaleye Management Inc. Boston, MA3.46MShares$11.2 Million2.74% of portfolio
-
Baillie Gifford & CO2.71MShares$8.75 Million0.01% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $212M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...